
Opinion|Videos|March 31, 2025
Studying the Association Between Elevated Lp(a) Levels and Risk of Atherosclerotic Disease
Experts discuss the relationship between lipoprotein(a) (Lp[a]) levels and atherosclerotic cardiovascular disease (ASCVD) risk, with findings from a large US population study, and explore how these findings could impact clinical practice and the management of patients at risk for ASCVD.
Advertisement
Video content above is prompted by the following:
- In the introduction, I mentioned that Lp(a) is considered an independent and significant risk factor for ASCVD and aortic stenosis. Dr Wong, you recently studied the relationship between Lp(a) level and ASCVD risk in a large US population. Could you describe your findings?
- Dr Saseen, how might findings like these impact clinical practice?
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Amid SOHO Data, Reviewers of BTK Inhibitors in MCL Call for Trials
2
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
3
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
4
Cross-Trial Vitiligo Data: What Payers Can and Can't Compare
5





